2023: The Best Year Ever for Future Pharmacology (and Even Better Years to Come)
- “Antiviral Drug Discovery and Development: Current Innovations and Future Trends”, edited by Zhan; submission deadline: 31 January 2024 [6].
- “Novel Therapeutic Approach to Inflammation and Pain”, edited by Mattioli and Mariano; submission deadline: 31 March 2024 [7].
- “Unveiling New Insights and Treatment Options for Ocular Surface Diseases”, edited by Tirassa and Mallone; submission deadline: 30 April 2023 [8].
Funding
Conflicts of Interest
References
- Future Pharmacology: Volume 3. 2023. Available online: https://www.mdpi.com/2673-9879/3 (accessed on 12 December 2023).
- Marques, L.; Vale, N. Unraveling the Impact of Salbutamol Polytherapy: Clinically Relevant Drug Interactions. Future Pharmacol. 2023, 3, 296–316. [Google Scholar] [CrossRef]
- Natale, F.; Molinari, R.; Franzese, R.; Mollo, N.; Cimmino, G. Bempedoic Acid and Statins in Lipid-Lowering Strategy: Which Came First, the Egg or the Chicken? Future Pharmacol. 2023, 3, 392–406. [Google Scholar] [CrossRef]
- Thong, E.H.; Lee, E.C.Y.; Yun, C.-Y.; Li, T.Y.W.; Sia, C.-H. Aspirin Therapy, Cognitive Impairment, and Dementia—A Review. Future Pharmacol. 2023, 3, 144–161. [Google Scholar] [CrossRef]
- Pharmacology and Toxicology of Amphetamine Type Stimulants. Available online: https://www.mdpi.com/about/announcements/5783 (accessed on 12 December 2023).
- Zhan, P. (Ed.) Antiviral Drug Discovery and Development: Current Innovations and Future Trends; MDPI: Basel, Switzerland; Available online: https://www.mdpi.com/journal/futurepharmacol/special_issues/QOPX8L93NB (accessed on 12 December 2023).
- Mattioli, R.; Mariano, A. (Eds.) Novel Therapeutic Approach to Inflammation and Pain; MDPI: Basel, Switzerland; Available online: https://www.mdpi.com/journal/futurepharmacol/special_issues/RH2D575VPI (accessed on 12 December 2023).
- Tirassa, P.; Rosso, P. (Eds.) Unveiling New Insights and Treatment Options for Ocular Surface Diseases; MDPI: Basel, Switzerland; Available online: https://www.mdpi.com/journal/futurepharmacol/special_issues/2J2P7GPJ4S (accessed on 12 December 2023).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Schifano, F. 2023: The Best Year Ever for Future Pharmacology (and Even Better Years to Come). Future Pharmacol. 2024, 4, 1-2. https://doi.org/10.3390/futurepharmacol4010001
Schifano F. 2023: The Best Year Ever for Future Pharmacology (and Even Better Years to Come). Future Pharmacology. 2024; 4(1):1-2. https://doi.org/10.3390/futurepharmacol4010001
Chicago/Turabian StyleSchifano, Fabrizio. 2024. "2023: The Best Year Ever for Future Pharmacology (and Even Better Years to Come)" Future Pharmacology 4, no. 1: 1-2. https://doi.org/10.3390/futurepharmacol4010001